Fighting Cancer New Technology And Super Foods

In the last 25 years, immunology has answered one of the central questions about cancer – why cancer cells are not destroyed by the patient's immune system. Based on the research of Dr. Lentz and others, we now know that cancer cells create inhibitors to shield themselves from attack, much the way military aircraft produce "chaff" to fend off defensive fire.
Using a technology akin to dialysis, Immunepheresis removes these inhibitors from the patient's bloodstream, eliciting a natural immune system response that in most cases leads to rapid tumor shrinkage. The method has been used in human clinical trials for over 15 years, and in several hundred patients, with consistent, encouraging data on efficacy and safety.
Immunepheresis appears to be effective in a wide range of solid tumor cancers, though not in all patients: the key prognostic variables are (a) cancer stage and (b) strength of the patient's immune system before treatment begins.
Importantly, Immunepheresis has usually shown results that are better than chemotherapy or radiation in terms of killing most malignant tumors. Even in patients with Stage IV disease; multiple metastases and major tumor burden; extensive prior chemotherapy; and exhaustion of conventional therapeutic options, Immunepheresis has shown significant clinical responses (i.e. >50% reduction in measurable tumor volume).